Jeff Crowe - Ataxia Stem Cell Patient

Jeff Crowe has Ataxia, an hereditary genetic disorder affecting his nervous system. He came to China to receive adult stem cell therapy in the hopes of improving his condition and to push the hands on the clock back a bit. People with Ataxia are often mistaken for being very drunk. Their speech can be slurred. They can appear clumsy and uncoordinated. They suffer double-vision, dizziness and difficulties with depth perception. Jeff refused to accept the news that there was nothing that could be done about it. After receiving treatments of adult stem cells from donated umbilical cord blood his balance and walking abilities improved amongst other things. Adult stem cell therapy is not a cure for Ataxia. After symptoms began to progress again he returned for a second round of transplants. This video was shot during that time.

Improvement statistics

Based on follow-up reports from 143 patients across 413 forms, here is the percentage who self-reported any improvement after treatment.

83%
Speech (babbling for infants)
reported improvement · N=114
83%
Drooling
reported improvement · N=54
83%
Swallowing
reported improvement · N=101
79%
Fine hand movements
reported improvement · N=129
78%
Memory
reported improvement · N=60
77%
Muscle stiffness
reported improvement · N=102
76%
Coordination
reported improvement · N=129
75%
Weight loss
reported improvement · N=85
75%
Control of movement
reported improvement · N=126
75%
Tremors
reported improvement · N=90

About this data

Patients self-assess each symptom on a 5-point scale (Worse / No improvement / Small / Moderate / Significant) at follow-up checkpoints after treatment, comparing to their pre-treatment baseline. "Reported improvement" combines the small, moderate and significant buckets. Data is updated daily from our internal patient registry. As with any medical treatment, past results do not guarantee future outcomes — improvements vary from patient to patient.

Internationally accredited

Held to global laboratory and biologics standards.